BioSpace News Archive

Drug Development

Tessa Therapeutics Doses First Patient in Phase 1b Clinical Trial Investigating TT11 in Combination with Nivolumab for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)

Tessa Therapeutics Ltd. announced the dosing of the first patient in a Phase 1b clinical trial investigating TT11, the company’s autologous CD30 chimeric antigen receptor T-cell therapy, in combination with Bristol Myers Squibb’s nivolumab as a potential second-line treatment for patients with relapsed or refractory CD30-positive classical Hodgkin lymphoma.

August 17, 2022
·
6 min read
Biotech Bay

Arine Secures $29 Million to Meet High Demand for Its Medication Intelligence Platform

Arine, a next-generation medication intelligence company, announced that it has raised $29 million in Series B funding composed of equity and debt financing.

August 17, 2022
·
3 min read
Biotech Beach

AiViva Biopharma Receives New Patent

AiViva Biopharma, a clinical stage biopharmaceutical company has received patent US 11,400,089 on August 2, 2022.

August 17, 2022
·
1 min read
Transcatheter Mitral Valve Repair & Replacement Market: Rise in the Number of Pipeline Devices to Fuel the Market Growth

Wilmington, Delaware, United States, Transparency Market Research Inc. – Mitral valve is positioned between the left atrium and left ventricle.

August 17, 2022
·
5 min read
Electrosurgical/Electrosurgery Devices Market Is Expected To Reach USD 8.17 Billion by 2028

The global electrosurgical/electrosurgery devices market size is expected to reach USD 8.17 Billion in 2028 and register a CAGR of 6.6%, according to the latest report by Reports and Data.

August 17, 2022
·
7 min read